Swiss drug prices still soar above European levels
Compared with nine other European countries, Switzerland remains a high-price island for medicines, according to an annual survey by health insurer body santésuisse and pharma research group Interpharma.
This content was published on
2 minutes
Keystone-SDA/dos
Português
pt
Preços de remédios na Suíça sobem acima dos níveis europeus
The price difference was again most marked for generic drugs – i.e. mass-produced copies of established products, the groups said on Tuesday. In February 2022, generics were almost twice as cheap (48.4%) in the nine other European nations studied than in Switzerland, an increase on last year’s 43.5%. The 250 top-selling patented drugs were meanwhile 8.8% cheaper elsewhere; the top patent-expired drugs were 15.4% cheaper.
While the rising price gap last year was particularly due to fluctuations in the euro-franc exchange rate, the general situation still calls for political action, said Christoph Kilchenmann of santésuisse.
“[Insurance] premium payers unfortunately spend much too much on medicines, which has a direct repercussion on rising premiums,” he said. He claimed Swiss consumers spend up to CHF750 million too much on drugs, and called on parliament to rein in prices.
Hot political potato
Health costs are an ongoing issue in Switzerland, and the national price watchdog has also previously said that politicians should approve a reference system to curb the high price of medicines.
As for rising insurance premiums, parliament is due to discuss two separate people’s initiatives in the coming weeks, both of which aim to stabilise costs by linking premium levels with salary levels. Neither proposal will come before Swiss voters this year.
Interpharma director René Buholzer meanwhile claimed on Tuesday that drug prices, which make up “only 12% of overall [health] costs”, were not the big driver of pricey healthcare. For him, the best solution would be to facilitate a faster approval of “innovative medicines” into the official list of products.
Switzerland abstains from vote on Palestinian bid for full UN membership
This content was published on
On Friday, Switzerland abstained from the vote at the General Assembly on granting the Palestinians new rights at the United Nations (UN).
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland remains high price island for drugs
This content was published on
The price of medical drugs in Switzerland remains higher than in other major European markets, especially for generic drugs.
Price watchdog demands action over expensive Swiss medicines
This content was published on
Generic drugs are now two and a half times more expensive in Switzerland than in other European countries, according to the Swiss price watchdog.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.